Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin.

Scherzer, Thomas-Matthias, Stättermayer, Albert Friedrich, Strasser, Michael, Laferl, Hermann, Maieron, Andreas, Stauber, Rudolf, Datz, Christian, Dulic-Lakovic, Emina, Steindl-Munda, Petra, Hofer, Harald and Ferenci, Peter (2011) Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin. Hepatology (Baltimore, Md.), 54 (5). pp. 1518-26. ISSN 1527-3350

Full text not available from this repository.

Item Type:	Article
Divisions:	Ordensklinikum Linz Barmherzige Schwestern > Interne IV: Gastroenterologie & Hepatologie, Endokrinologie und Stoffwechsel, Ernährungsmedizin
Depositing User:	Prof. Dr. Rainer Schöfl
Date Deposited:	16 Nov 2021 11:40
Last Modified:	17 Feb 2025 09:34
URI:	https://eprints.vinzenzgruppe.at/id/eprint/9358

Edit Item